B2GP1 Human - Human Beta 2 GlycoProtein-I
Cat# OPPA01429-5MG
Size : 5mg
Brand : Aviva Systems Biology
Contact local distributor :
Phone : +1 850 650 7790
B2GP1 Human - Human Beta 2 GlycoProtein-I (OPPA01429)
| Datasheets/Manuals | Printable datasheet for B2GP1 Human - Human Beta 2 GlycoProtein-I (OPPA01429) |
|---|
| Product Format | Lyophilized 0.02M NaH4HCO3 |
|---|---|
| Reconstitution and Storage | It is recommended to reconstitute the lyophilized APOH in phosphate buffer, pH > 7.0 containing 0.15M NaCl. Although stable at room temperature for 3 weeks, should be stored between 2-8°C. |
| Purity | Greater than 96.0%. |
| Source | Human Plasma |
| Publications | Effects of antibodies against human parvovirus B19 on angiogenic signaling |
| Warning | Starting material tested and found negative for HIV I and II antibodies, Hepatitis B surface antigen, and Hepatitis C antibodies. |
| Gene Symbol | B2GP1 |
|---|---|
| Alias Symbols | BG, B2G1, B2GP1 |
| NCBI Gene Id | 350 |
| Protein Name | Beta-2-glycoprotein 1 |
| Description of Target | Human APOH produced in Human Plasma having a pI of 5.6-6.4. It’s a major phospholipid binding protein and an important component to measure in the assessment of anti-phospholipid syndrome. APOH is also more specific than anti-cardiolipin antibodies and its presence correlates better with thrombotic risk. |
| Uniprot ID | P02749 |
| Protein Accession # | NP_000033.2 |
| Molecular Weight | 50 kDa |